Fuan Pharmaceutical (Group) Co., Ltd. (300194.SZ)
CNY 4.11
(2.49%)
CNY 4.11
(2.49%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 1.36 Billion CNY | -0.04% |
| 2022 | 1.41 Billion CNY | -8.31% |
| 2021 | 1.54 Billion CNY | -0.46% |
| 2020 | 1.54 Billion CNY | -12.61% |
| 2019 | 1.77 Billion CNY | 7.66% |
| 2018 | 1.64 Billion CNY | 39.59% |
| 2017 | 1.17 Billion CNY | 93.8% |
| 2016 | 608.57 Million CNY | 94.45% |
| 2015 | 312.97 Million CNY | 119.2% |
| 2014 | 142.77 Million CNY | 22.61% |
| 2013 | 116.44 Million CNY | -22.68% |
| 2012 | 150.6 Million CNY | 5.11% |
| 2011 | 143.28 Million CNY | -33.55% |
| 2010 | 215.63 Million CNY | 37.09% |
| 2009 | 157.28 Million CNY | 83.9% |
| 2008 | 85.52 Million CNY | 312.31% |
| 2007 | 20.74 Million CNY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 351.73 Million CNY | -14.84% |
| 2024 Q3 | 292.02 Million CNY | -16.97% |
| 2024 Q1 | 413.02 Million CNY | 33.85% |
| 2023 Q3 | 350.82 Million CNY | -0.19% |
| 2023 Q1 | 402.07 Million CNY | 15.67% |
| 2023 FY | 1.41 Billion CNY | -0.04% |
| 2023 Q4 | 308.57 Million CNY | -12.04% |
| 2023 Q2 | 351.49 Million CNY | -12.58% |
| 2022 Q1 | 336.59 Million CNY | -5.29% |
| 2022 Q4 | 347.59 Million CNY | -7.37% |
| 2022 Q2 | 354.13 Million CNY | 5.21% |
| 2022 FY | 1.41 Billion CNY | -8.31% |
| 2022 Q3 | 375.23 Million CNY | 5.96% |
| 2021 Q1 | 408.47 Million CNY | 9.16% |
| 2021 Q3 | 403.77 Million CNY | 7.95% |
| 2021 Q4 | 355.39 Million CNY | -11.98% |
| 2021 FY | 1.54 Billion CNY | -0.46% |
| 2021 Q2 | 374.02 Million CNY | -8.43% |
| 2020 Q4 | 374.21 Million CNY | -14.07% |
| 2020 Q3 | 435.47 Million CNY | 17.43% |
| 2020 Q2 | 370.84 Million CNY | 0.69% |
| 2020 Q1 | 368.28 Million CNY | -7.87% |
| 2020 FY | 1.54 Billion CNY | -12.61% |
| 2019 FY | 1.77 Billion CNY | 7.66% |
| 2019 Q4 | 399.72 Million CNY | -10.7% |
| 2019 Q3 | 447.64 Million CNY | -2.67% |
| 2019 Q2 | 459.92 Million CNY | -1.1% |
| 2019 Q1 | 465.04 Million CNY | 28.29% |
| 2018 Q3 | 378.58 Million CNY | -8.75% |
| 2018 FY | 1.64 Billion CNY | 39.59% |
| 2018 Q1 | 490.3 Million CNY | 29.55% |
| 2018 Q2 | 414.89 Million CNY | -15.38% |
| 2018 Q4 | 362.48 Million CNY | -4.25% |
| 2017 FY | 1.17 Billion CNY | 93.8% |
| 2017 Q2 | 263.57 Million CNY | 25.59% |
| 2017 Q4 | 378.47 Million CNY | 16.11% |
| 2017 Q1 | 209.86 Million CNY | 7.4% |
| 2017 Q3 | 325.96 Million CNY | 23.67% |
| 2016 Q3 | 175.91 Million CNY | 25.07% |
| 2016 FY | 608.57 Million CNY | 94.45% |
| 2016 Q4 | 195.4 Million CNY | 11.08% |
| 2016 Q2 | 140.64 Million CNY | 45.58% |
| 2016 Q1 | 96.61 Million CNY | 0.92% |
| 2015 Q1 | 34.01 Million CNY | -4.59% |
| 2015 Q3 | 104.6 Million CNY | 33.05% |
| 2015 FY | 312.97 Million CNY | 119.2% |
| 2015 Q4 | 95.72 Million CNY | -8.48% |
| 2015 Q2 | 78.62 Million CNY | 131.11% |
| 2014 Q4 | 35.65 Million CNY | 25.62% |
| 2014 FY | 142.77 Million CNY | 22.61% |
| 2014 Q1 | 37.44 Million CNY | 11.42% |
| 2014 Q2 | 41.29 Million CNY | 10.27% |
| 2014 Q3 | 28.38 Million CNY | -31.26% |
| 2013 Q4 | 33.6 Million CNY | 38.69% |
| 2013 FY | 116.44 Million CNY | -22.68% |
| 2013 Q1 | 32.74 Million CNY | 23.0% |
| 2013 Q2 | 25.86 Million CNY | -21.0% |
| 2013 Q3 | 24.23 Million CNY | -6.32% |
| 2012 FY | 150.6 Million CNY | 5.11% |
| 2012 Q3 | 39.47 Million CNY | -14.65% |
| 2012 Q1 | 38.25 Million CNY | 62.71% |
| 2012 Q4 | 26.61 Million CNY | -32.57% |
| 2012 Q2 | 46.25 Million CNY | 20.89% |
| 2011 Q3 | 24.01 Million CNY | -44.92% |
| 2011 Q4 | 23.51 Million CNY | -2.09% |
| 2011 Q2 | 43.6 Million CNY | -16.41% |
| 2011 FY | 143.28 Million CNY | -33.55% |
| 2011 Q1 | 52.15 Million CNY | -5.51% |
| 2010 Q2 | 57.11 Million CNY | 9.88% |
| 2010 Q1 | 51.98 Million CNY | 0.0% |
| 2010 Q4 | 55.2 Million CNY | 7.55% |
| 2010 Q3 | 51.32 Million CNY | -10.14% |
| 2010 FY | 215.63 Million CNY | 37.09% |
| 2009 FY | 157.28 Million CNY | 83.9% |
| 2008 FY | 85.52 Million CNY | 312.31% |
| 2007 FY | 20.74 Million CNY | 0.0% |